Pascal H. P. de Jong

Learn More
OBJECTIVES To compare 1-year clinical efficacy of (1) initial triple disease-modifying antirheumatic drug therapy (iTDT) with initial methotrexate (MTX) monotherapy (iMM) and (2) different glucocorticoid (GC) bridging therapies: oral versus a single intramuscular injection in early rheumatoid arthritis. METHODS In a single-blinded randomised clinical(More)
INTRODUCTION Genetic and disease-related factors give rise to a wide spectrum of glucocorticoid (GC) sensitivity in rheumatoid arthritis (RA). In clinical practice, GC treatment is not adapted to these differences in GC sensitivity. In vitro assessment of GC sensitivity before the start of therapy could allow more individualized GC therapy. The aim of the(More)
INTRODUCTION Patients with rheumatoid arthritis (RA) can be separated into two major subpopulations based on the absence or presence of serum anti-citrullinated protein antibodies (ACPAs). The more severe disease course in ACPA(+) RA and differences in treatment outcome between these subpopulations suggest that ACPA(+) and ACPA(-) RA are different disease(More)
Current power harvesting research has focused on bending beams and determining power output under a given excitation. For the European CleanSky – Green Rotor Craft project a tool is being developed which optimizes the piezoelectric material and placement thereof for power harvesting. It focuses on beam-like structures exhibiting more complex dynamics where(More)
  • 1